Clinical Trial Update: A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with fluzoparib and chemotherapy or fluzoparib in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: The Second Affiliated Hospital of Shandong First Medical University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN